| Stage | BRK-B | % of rev | AIG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $102B | 100.00% | $7.4B | 100.00% | BRK-B ×13.68 |
| Gross profit | $55.9B | 54.87% | $7.4B | 100.00% | AIG +45.1pp |
| Operating income | $17.1B | 16.77% | $1.2B | 16.39% | BRK-B +0.4pp |
| Pre-tax income | $31.8B | 31.25% | $1.1B | 15.03% | BRK-B +16.2pp |
| Net income | $25.8B | 25.31% | $849M | 11.41% | BRK-B +13.9pp |
| Stage | BRK-B | AIG | Gap · A − B |
|---|---|---|---|
| Revenue | $102B100.00% | $7.4B100.00% | BRK-B ×13.68 |
| Gross profit | 54.87%$55.9B | 100.00%$7.4B | AIG +45.1pp |
| Operating income | 16.77%$17.1B | 16.39%$1.2B | BRK-B +0.4pp |
| Pre-tax income | 31.25%$31.8B | 15.03%$1.1B | BRK-B +16.2pp |
| Net income |
| 25.31%$25.8B |
| 11.41%$849M |
| BRK-B +13.9pp |
None
No disclosed counterparties: BRK-B.